The Switzerland-based Hoffmann La-Roche Inc., a global leader in pharmaceutical production, today have acquired the U.S. biotech firm Anadys Pharmaceuticals Inc.

全球医药产品巨头瑞士霍夫曼 拉-罗氏公司今天以每股3.7美元，或2.3亿美元的总价收购了美国生物科技公司Anadys Parmaceuticals Inc。

youdao

Anadys Pharmaceuticals is in early-stage human tests with drugs that stimulate the so-called TLR-7 receptor on immune cells to produce interferon just where it is needed.

FORBES: Magazine Article